Corporate | 11 November 2003 07:45

Eckert & Ziegler AG english

Improved result for Eckert & Ziegler AG Corporate-news announcement sent by DGAP. The sender is solely responsible for the contents of this announcement. ——————————————————————————– Berlin, 11.11.2003. Eckert & Ziegler AG (ISIN DE 0005659700), a specialist in radiation sources for medicine and industry, improved the net income from continuing operations of its continuous business activity in the third quarter of 2003 to 482,000 EUR, thus roughly balancing its cumulative result after taxes for the first nine months of the year. As late as the second quarter, the Berlin based company had shown a quarterly after-tax loss of 652,000 EUR. As expected, third-quarter sales figures approached 6 million EUR, around 20% lower than in the comparable period for last year. This decline is due to sales of a business division in the USA, the weakness of the dollar, and the announced discontinuation of products for treating cardiac disease. The expected total revenue for 2003 is about 30 mm EUR and 0.25 EUR/ share net earnings. For next year management expects double digit revenue growth at current EUR/ US$ exchange rates, and an earning increase to about 0.4 EUR/ share. To support these increases, management will reassign certain priorities and responsibilities within the holding company. The Executive Board For further questions, please contact: Eckert & Ziegler AG, Karolin Riehle, Investor Relations Robert-Rössle-Str. 10, 13125 Berlin, Germany Phone: +49 (0) 30 / 94 10 84-138 www.ezag.de end of message, (c)DGAP 11.11.2003 ——————————————————————————– WKN: 565970; ISIN: DE0005659700; Index: Listed: Geregelter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin- Bremen, Düsseldorf, Hamburg, Hannover und Stuttgart 110745 Nov 03